Paltac Corporation (TYO:8283)
5,019.00
+25.00 (0.50%)
Jan 23, 2026, 3:30 PM JST
Paltac Revenue
Paltac had revenue of 309.09B JPY in the quarter ending September 30, 2025, with 2.04% growth. This brings the company's revenue in the last twelve months to 1.21T. In the fiscal year ending March 31, 2025, Paltac had annual revenue of 1.19T with 3.14% growth.
Revenue (ttm)
1.21T
Revenue Growth
+3.14%
P/S Ratio
0.25
Revenue / Employee
155.75M
Employees
7,787
Market Cap
306.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.19T | 36.13B | 3.14% |
| Mar 31, 2024 | 1.15T | - | - |
| Mar 31, 2018 | - | - | - |
| Mar 31, 2016 | - | - | - |
| Mar 31, 2014 | - | - | - |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lion Corporation | 416.73B |
| Rohto Pharmaceutical | 333.80B |
| KOSE Holdings | 324.54B |
| Earth | 177.37B |
| Pola Orbis Holdings | 169.97B |
| Kobayashi Pharmaceutical | 163.18B |
| Pigeon | 108.66B |
| MTG Co., Ltd. | 98.81B |